In conclusion, MYP was effective in recovering major symptoms of ME/CFS and was associated with the regulation of dopaminergic and serotonergic pathways and TGF-β expression in the brain, as well as anti-inflammatory and anti-oxidant mechanisms in internal organs. The gene discussed is TGFB1; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.